LYS006
LTA4H-IN-1 is a potent inhibitor of leukotriene A4 hydrolase (LTA4H) extracted from patent WO2015092740A1, example 29, has an IC50 of 2 nM. LTA4H-IN-1 can be used for the research of inflammatory and autoimmune disorders[1].
Product Specifications
CAS Number
1799681-85-8
Product Name Alternative
LTA4H-IN-1
UNSPSC
12352005
Target
Aminopeptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/lta4h-in-1.html
Purity
98.41
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(O)C[C@H](N)CN1N=C(C2=CC=C(OC3=NC=C(Cl)C=C3F)C=C2)N=N1
Molecular Formula
C16H14ClFN6O3
Molecular Weight
392.77
References & Citations
[1]Bollbuck B, et, al. Heteroaryl butanoic acid derivatives as leukotriene A4 hydrolase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of diseases. WO2015092740A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
LTA4H
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
KN219851BN 1 Kit
VEGF Receptor 2 (KDR) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
BNC680294-500 1x 500 µL
NKX2.2 (NX2/294), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
